TTP plc chosen by Cancer Research UK for technology advisory partnership
Cancer Research UK has selected Melbourn-based TTP for a technology advisory partnership.
The company will use its technology design and development expertise and its insight into the healthcare sector to assess discoveries made by the charities academic researchers.
TTP will review and evaluate clinical and commercial applications of emerging technologies to help CRUK’s work into the prevention, diagnosis and treatment of cancer.
Dr Michelle Griffin, clinical innovator at TTP plc, said: “Being chosen to work with such a prestigious organisation demonstrates our credibility and trusted experience within healthcare technology development. Our expertise across the sector compliments Cancer Research UK’s breadth of research techniques, and we look forward to applying this deep knowledge to find new and exciting methods to beat cancer, sooner.”
Tony Hickson, chief business officer at CRUK, said: “We have access to a fantastic portfolio of emerging tech through the Cancer Research UK academic community and are eager to see this reach the healthcare setting as soon as possible.
“Our partnership with TTP plc is a great opportunity for Cancer Research UK as it will enable us to deliver our most promising technologies to the clinic, shaping the future of how people with cancer are diagnosed, treated and monitored.”
TTP’s experience in progressing a product idea to manufacture will help the charity’s research in areas such as medical devices, diagnostics, sensors and artificial intelligence.
Read moreBusiness News
More by this authorPaul Brackley
This website and its associated newspaper are members of the Independent Press Standards Organisation (IPSO)